Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Gil Bar‐Sela"'
Case report: Conjunctival melanoma treated with relatlimab and nivolumab showing remarkable response
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Conjunctival melanoma, an uncommon form of ocular melanoma, shares some molecular characteristics with cutaneous melanoma and some with mucosal melanoma. Treatment of cases where it becomes advanced or metastatic raises unique treatment challenges. N
Externí odkaz:
https://doaj.org/article/524199d12a0c47e1bdbbe9c139f21a7c
Autor:
Maram Hilwi, Katherina Shulman, Inna Naroditsky, Sari Feld, Miriam Gross-Cohen, Ilanit Boyango, Soaad Soboh, Olga Vornicova, Malik Farhoud, Preeti Singh, Gil Bar-Sela, Hadassah Goldberg, Martin Götte, Andrew D. Sharrocks, Yaoyong Li, Ralph D. Sanderson, Neta Ilan, Israel Vlodavsky
Publikováno v:
Cell Death and Disease, Vol 15, Iss 3, Pp 1-13 (2024)
Abstract Unlike the intense research effort devoted to exploring the significance of heparanase in cancer, very little attention was given to Hpa2, a close homolog of heparanase. Here, we explored the role of Hpa2 in breast cancer. Unexpectedly, we f
Externí odkaz:
https://doaj.org/article/09ad1fee324e44e58f2c01dcb813d1a6
Publikováno v:
Diseases, Vol 12, Iss 11, p 290 (2024)
Background: This case report details the innovative use of selective internal radiation therapy (SIRT) with Yttrium-90 resin microspheres to treat a 73-year-old woman with a solitary fibrous tumor (SFT), a rare and challenging tumor type. SFTs often
Externí odkaz:
https://doaj.org/article/11a109fb09b34b11a186dc37b85ea702
Autor:
Omar Badran, Salvatore Campisi-Pinto, Mahmoud Abu Amna, Ilit Turgeman, Samih Yosef, Gil Bar-Sela
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
This study investigates breast cancer survival rates between 2000 and 2022 in northern Israel, focusing on ethnicity, socioeconomic status, age at diagnosis, and the Charlson Comorbidity Index. Analyzing data from Clalit Health Services, we studied 8
Externí odkaz:
https://doaj.org/article/8030ccba7bd644fb90e1ba30dc8be657
Autor:
Shlomit S. Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Lior Soussan-Gutman, Avital Bareket-Samish, Amir Sonnenblick, Noa Ben-Baruch, Ella Evron, Einav Nili Gal-Yam, Shani Paluch-Shimon, Gil Bar-Sela, Hadar Goldvaser, Salomon M. Stemmer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Data on using the 21-gene Recurrence Score (RS) testing on second breast cancer (BC; second primary or local recurrence) are lacking. This cohort study examined patients with first and second BC, who underwent 21-gene testing both times. It
Externí odkaz:
https://doaj.org/article/3bcf6bdee0c84eafb59930d692223e0a
Autor:
Itamar Averbuch, Ronen Stoff, Mor Miodovnik, Shlomit Fennig, Gil Bar‐Sela, Alexander Yakobson, Jonathan Daliot, Nethanel Asher, Eyal Fenig
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12065-12070 (2023)
Abstract Background Merkel cell carcinoma (MCC) is a rare and aggressive malignancy of the skin, affecting predominantly the fair‐skinned older population exposed to high levels of ultraviolet light. Immune suppression is considered a significant r
Externí odkaz:
https://doaj.org/article/a3ed64bea1fa4230946ceb76d10f6235
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/73402028099f45de8e148cd1887a30a0
Autor:
Gil Shamai, Amir Livne, António Polónia, Edmond Sabo, Alexandra Cretu, Gil Bar-Sela, Ron Kimmel
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
Programmed death ligand-1 (PD-L1) has been recently adopted for breast cancer as a predictive biomarker for immunotherapies. Here, the authors show that PD-L1 expression can be predicted from H&E-stained images using deep learning.
Externí odkaz:
https://doaj.org/article/5b68aac1fbab4761b473d7d5ad7e9884
Autor:
Miri Cohen, Yosi Shamay, Johanna Czamanski-Cohen, Katerina Shulman, Shoshana Keren Rosenberg, Mahmoud Abu-Amna, Ilit Turgeman, Ludmila Merkin Livshits, Revital Birenboim, Monica Dines, Gil Bar-Sela
Publikováno v:
Cells, Vol 12, Iss 20, p 2471 (2023)
Substantial evidence has accumulated showing that psychological distress affects immune regulation, the response to cancer treatment, and survival. The effect of psychological parameters on the effectiveness of immune checkpoint inhibitor (ICI) treat
Externí odkaz:
https://doaj.org/article/716e0e3ef40244f088c1ade32faa8ad1
Publikováno v:
Israel Journal of Health Policy Research, Vol 11, Iss 1, Pp 1-10 (2022)
Abstract Background In most countries, including those with national health insurance or comprehensive public insurance, some expenses for cancer treatment are borne by the ill and their families. Objectives This study aims to identify the areas of o
Externí odkaz:
https://doaj.org/article/62bf53f22902496dbd4236c3dd3ff0ce